Ligandrol (LGD-4033)
Contents
show
Increases in lean body mass and decrease in body fat and increases in strength, well-being, as well as healing possibilities.
What is Ligandrol?
Ligandrol is a nonsteroidal oral selective androgen receptor modulator discovered by Ligand Pharmaceuticals and is currently being developed by Viking Therapeutics for the treatment of muscle wasting and osteoporosis.
Ligandrol Study Conclusions
Despite no change in prostate-specific antigen during this short period, LGD-4033 was safe, had a good pharmacokinetic profile, and increased lean body mass.
Longer randomized studies should be conducted to assess its effectiveness in improving physical function and health outcomes in specific groups. [1] inside a white HDPE plastic bottle
Ligandrol Dosage
8-16mg/day
